Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Chromosomal Translocation in Hematologic Malignancies

Multiplex reverse transcription-polymerase chain reaction (M-RT-PCR) has been proved to possess great clinical potential for simultaneous screening of 29 chromosomal translocations in acute leukemia. To evaluate the clinical value of M-RT-PCR in hematologic malignancies, bone marrow samples from 90...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Huazhong University of Science and Technology. Medical sciences 2006, Vol.26 (6), p.661-663
Main Author: 黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73
cites cdi_FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73
container_end_page 663
container_issue 6
container_start_page 661
container_title Journal of Huazhong University of Science and Technology. Medical sciences
container_volume 26
creator 黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励
description Multiplex reverse transcription-polymerase chain reaction (M-RT-PCR) has been proved to possess great clinical potential for simultaneous screening of 29 chromosomal translocations in acute leukemia. To evaluate the clinical value of M-RT-PCR in hematologic malignancies, bone marrow samples from 90 patients with various hematologic malignancies, including 25 acute myelogenous leukemia (AML), 22 acute lymphoblastic leukemia (ALL), 27 chronic myelogenous leukemia (CML), 4 myeloproliferative diseases (MPD), 3 chronic lymphoblastic leukemia (CLL), 3 non-Hodgkin's lymphoma (NHL), 3 myelodysplastic syndrome (MDS), 2 multiple myeloma (MM) and 1 malignant histocytosis (MH) were subjected to both M-RT-PCR and chromosome karyotypic analysis. Some of cases were subjected to follow-up examination of M-RT-PCR during the period of clinical complete remission (CR) for detection of minimal residual leukemia. In our hand, 12 of 29 chromosomal translocation transcripts including TEL/PDGFR, DEK/CAN, MLL/AF6, AMLI/ETO, MLL/AF9, BCR/ABL, MLL/MLL, PML/RARα, TLS/ERG, E2A/HLF, EVⅡ and HOXⅡ were detected in 57 cases (63.3 %) of the 90 samples, which were in consistence with the results of karyotypic analysis. Furthermore, M-RT-PCR had also shown good clinical relevance when used as an approach to detect minimal residual leukemia. We concluded that M-RT-PCR could be used as an efficient and fast diagnostic tool not only in the initial diagnosis of hematologic malignancies but also in subsequent monitor of minimal residual leukemia.
doi_str_mv 10.1007/s11596-006-0608-2
format article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_tjykdxxb_e200606008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>23648748</cqvip_id><wanfj_id>tjykdxxb_e200606008</wanfj_id><sourcerecordid>tjykdxxb_e200606008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS1ERcvAA7BBEQtYoIB_EjtZViOgSK2KaFlbjnOdeurYUzuBmbfoI-MhI7GrLPtaut85_jkIvSH4E8FYfE6E1C0vMc6T46akz9AZaVtWElbT53nPBS2xYOwUvUxpg3EtOK1eoFMiWC2qhp6hx6vZTXbrYFf8hN8QExS3Ufmko91ONvjyR3D7EaLKjfWdsj5jSh86hQmxuLFj1isPYU7FjY4A3vqhCKagbeZjGEMKo3KLqQta_ZNmmwsY1RRcGKwurpSzg1deW0iv0IlRLsHrY12hX1-_3K4vysvrb9_X55elZrhtSmBadYaS2hgCRAiOcVVXytC-7qu-4T02nahN3wvQvOPQkY7RyrDeNK0iSrAV-rj4_lHeKD_ITZijzyfKabO_73e7TgLNP5sHbjL9YaG3MTzMkCY52qTBueXpUrCKNLRq6ky-f5IkLWfisKwQWUAdQ0oRjNxGO6q4lwTLQ7xyiVfmS8hDvJJmzduj-dyN0P9XHPPMwLuj6V3ww0POQnZK3xvrIMt51WSK_QVKX68_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19637196</pqid></control><display><type>article</type><title>Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Chromosomal Translocation in Hematologic Malignancies</title><source>Springer Nature</source><creator>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</creator><creatorcontrib>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</creatorcontrib><description>Multiplex reverse transcription-polymerase chain reaction (M-RT-PCR) has been proved to possess great clinical potential for simultaneous screening of 29 chromosomal translocations in acute leukemia. To evaluate the clinical value of M-RT-PCR in hematologic malignancies, bone marrow samples from 90 patients with various hematologic malignancies, including 25 acute myelogenous leukemia (AML), 22 acute lymphoblastic leukemia (ALL), 27 chronic myelogenous leukemia (CML), 4 myeloproliferative diseases (MPD), 3 chronic lymphoblastic leukemia (CLL), 3 non-Hodgkin's lymphoma (NHL), 3 myelodysplastic syndrome (MDS), 2 multiple myeloma (MM) and 1 malignant histocytosis (MH) were subjected to both M-RT-PCR and chromosome karyotypic analysis. Some of cases were subjected to follow-up examination of M-RT-PCR during the period of clinical complete remission (CR) for detection of minimal residual leukemia. In our hand, 12 of 29 chromosomal translocation transcripts including TEL/PDGFR, DEK/CAN, MLL/AF6, AMLI/ETO, MLL/AF9, BCR/ABL, MLL/MLL, PML/RARα, TLS/ERG, E2A/HLF, EVⅡ and HOXⅡ were detected in 57 cases (63.3 %) of the 90 samples, which were in consistence with the results of karyotypic analysis. Furthermore, M-RT-PCR had also shown good clinical relevance when used as an approach to detect minimal residual leukemia. We concluded that M-RT-PCR could be used as an efficient and fast diagnostic tool not only in the initial diagnosis of hematologic malignancies but also in subsequent monitor of minimal residual leukemia.</description><identifier>ISSN: 1672-0733</identifier><identifier>EISSN: 1993-1352</identifier><identifier>DOI: 10.1007/s11596-006-0608-2</identifier><identifier>PMID: 17357482</identifier><language>eng</language><publisher>China: Department of Hematology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology,Wuhan 430030, China</publisher><subject>Hematologic Neoplasms - genetics ; Humans ; Reverse Transcriptase Polymerase Chain Reaction ; Translocation, Genetic ; 染色体 ; 逆转录聚合酶链反应</subject><ispartof>Journal of Huazhong University of Science and Technology. Medical sciences, 2006, Vol.26 (6), p.661-663</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73</citedby><cites>FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85740A/85740A.jpg</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17357482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</creatorcontrib><title>Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Chromosomal Translocation in Hematologic Malignancies</title><title>Journal of Huazhong University of Science and Technology. Medical sciences</title><addtitle>Journal of Zuazhong University of Science and Technology: Medical Edition</addtitle><description>Multiplex reverse transcription-polymerase chain reaction (M-RT-PCR) has been proved to possess great clinical potential for simultaneous screening of 29 chromosomal translocations in acute leukemia. To evaluate the clinical value of M-RT-PCR in hematologic malignancies, bone marrow samples from 90 patients with various hematologic malignancies, including 25 acute myelogenous leukemia (AML), 22 acute lymphoblastic leukemia (ALL), 27 chronic myelogenous leukemia (CML), 4 myeloproliferative diseases (MPD), 3 chronic lymphoblastic leukemia (CLL), 3 non-Hodgkin's lymphoma (NHL), 3 myelodysplastic syndrome (MDS), 2 multiple myeloma (MM) and 1 malignant histocytosis (MH) were subjected to both M-RT-PCR and chromosome karyotypic analysis. Some of cases were subjected to follow-up examination of M-RT-PCR during the period of clinical complete remission (CR) for detection of minimal residual leukemia. In our hand, 12 of 29 chromosomal translocation transcripts including TEL/PDGFR, DEK/CAN, MLL/AF6, AMLI/ETO, MLL/AF9, BCR/ABL, MLL/MLL, PML/RARα, TLS/ERG, E2A/HLF, EVⅡ and HOXⅡ were detected in 57 cases (63.3 %) of the 90 samples, which were in consistence with the results of karyotypic analysis. Furthermore, M-RT-PCR had also shown good clinical relevance when used as an approach to detect minimal residual leukemia. We concluded that M-RT-PCR could be used as an efficient and fast diagnostic tool not only in the initial diagnosis of hematologic malignancies but also in subsequent monitor of minimal residual leukemia.</description><subject>Hematologic Neoplasms - genetics</subject><subject>Humans</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Translocation, Genetic</subject><subject>染色体</subject><subject>逆转录聚合酶链反应</subject><issn>1672-0733</issn><issn>1993-1352</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS1ERcvAA7BBEQtYoIB_EjtZViOgSK2KaFlbjnOdeurYUzuBmbfoI-MhI7GrLPtaut85_jkIvSH4E8FYfE6E1C0vMc6T46akz9AZaVtWElbT53nPBS2xYOwUvUxpg3EtOK1eoFMiWC2qhp6hx6vZTXbrYFf8hN8QExS3Ufmko91ONvjyR3D7EaLKjfWdsj5jSh86hQmxuLFj1isPYU7FjY4A3vqhCKagbeZjGEMKo3KLqQta_ZNmmwsY1RRcGKwurpSzg1deW0iv0IlRLsHrY12hX1-_3K4vysvrb9_X55elZrhtSmBadYaS2hgCRAiOcVVXytC-7qu-4T02nahN3wvQvOPQkY7RyrDeNK0iSrAV-rj4_lHeKD_ITZijzyfKabO_73e7TgLNP5sHbjL9YaG3MTzMkCY52qTBueXpUrCKNLRq6ky-f5IkLWfisKwQWUAdQ0oRjNxGO6q4lwTLQ7xyiVfmS8hDvJJmzduj-dyN0P9XHPPMwLuj6V3ww0POQnZK3xvrIMt51WSK_QVKX68_</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</creator><general>Department of Hematology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology,Wuhan 430030, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2006</creationdate><title>Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Chromosomal Translocation in Hematologic Malignancies</title><author>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Hematologic Neoplasms - genetics</topic><topic>Humans</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Translocation, Genetic</topic><topic>染色体</topic><topic>逆转录聚合酶链反应</topic><toplevel>online_resources</toplevel><creatorcontrib>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Journal of Huazhong University of Science and Technology. Medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>黄梅 李春蕊 黄亮 周剑峰 邓金牛 刘文励</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Chromosomal Translocation in Hematologic Malignancies</atitle><jtitle>Journal of Huazhong University of Science and Technology. Medical sciences</jtitle><addtitle>Journal of Zuazhong University of Science and Technology: Medical Edition</addtitle><date>2006</date><risdate>2006</risdate><volume>26</volume><issue>6</issue><spage>661</spage><epage>663</epage><pages>661-663</pages><issn>1672-0733</issn><eissn>1993-1352</eissn><abstract>Multiplex reverse transcription-polymerase chain reaction (M-RT-PCR) has been proved to possess great clinical potential for simultaneous screening of 29 chromosomal translocations in acute leukemia. To evaluate the clinical value of M-RT-PCR in hematologic malignancies, bone marrow samples from 90 patients with various hematologic malignancies, including 25 acute myelogenous leukemia (AML), 22 acute lymphoblastic leukemia (ALL), 27 chronic myelogenous leukemia (CML), 4 myeloproliferative diseases (MPD), 3 chronic lymphoblastic leukemia (CLL), 3 non-Hodgkin's lymphoma (NHL), 3 myelodysplastic syndrome (MDS), 2 multiple myeloma (MM) and 1 malignant histocytosis (MH) were subjected to both M-RT-PCR and chromosome karyotypic analysis. Some of cases were subjected to follow-up examination of M-RT-PCR during the period of clinical complete remission (CR) for detection of minimal residual leukemia. In our hand, 12 of 29 chromosomal translocation transcripts including TEL/PDGFR, DEK/CAN, MLL/AF6, AMLI/ETO, MLL/AF9, BCR/ABL, MLL/MLL, PML/RARα, TLS/ERG, E2A/HLF, EVⅡ and HOXⅡ were detected in 57 cases (63.3 %) of the 90 samples, which were in consistence with the results of karyotypic analysis. Furthermore, M-RT-PCR had also shown good clinical relevance when used as an approach to detect minimal residual leukemia. We concluded that M-RT-PCR could be used as an efficient and fast diagnostic tool not only in the initial diagnosis of hematologic malignancies but also in subsequent monitor of minimal residual leukemia.</abstract><cop>China</cop><pub>Department of Hematology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology,Wuhan 430030, China</pub><pmid>17357482</pmid><doi>10.1007/s11596-006-0608-2</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1672-0733
ispartof Journal of Huazhong University of Science and Technology. Medical sciences, 2006, Vol.26 (6), p.661-663
issn 1672-0733
1993-1352
language eng
recordid cdi_wanfang_journals_tjykdxxb_e200606008
source Springer Nature
subjects Hematologic Neoplasms - genetics
Humans
Reverse Transcriptase Polymerase Chain Reaction
Translocation, Genetic
染色体
逆转录聚合酶链反应
title Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Chromosomal Translocation in Hematologic Malignancies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T22%3A00%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiplex%20Reverse%20Transcription-Polymerase%20Chain%20Reaction%20for%20Simultaneous%20Screening%20of%2029%20Chromosomal%20Translocation%20in%20Hematologic%20Malignancies&rft.jtitle=Journal%20of%20Huazhong%20University%20of%20Science%20and%20Technology.%20Medical%20sciences&rft.au=%E9%BB%84%E6%A2%85%20%E6%9D%8E%E6%98%A5%E8%95%8A%20%E9%BB%84%E4%BA%AE%20%E5%91%A8%E5%89%91%E5%B3%B0%20%E9%82%93%E9%87%91%E7%89%9B%20%E5%88%98%E6%96%87%E5%8A%B1&rft.date=2006&rft.volume=26&rft.issue=6&rft.spage=661&rft.epage=663&rft.pages=661-663&rft.issn=1672-0733&rft.eissn=1993-1352&rft_id=info:doi/10.1007/s11596-006-0608-2&rft_dat=%3Cwanfang_jour_proqu%3Etjykdxxb_e200606008%3C/wanfang_jour_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3098-e3cabf215ff1e177600454af2d5d4d86d0fb75fdd7ec6b6eb1b324f3df89a1a73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19637196&rft_id=info:pmid/17357482&rft_cqvip_id=23648748&rft_wanfj_id=tjykdxxb_e200606008&rfr_iscdi=true